β2-Chimaerin Is a High Affinity Receptor for the Phorbol Ester Tumor Promoters

β2-chimaerin, a member of the GTPase-activating proteins for the small GTP-binding protein p21Rac, possesses a single cysteine-rich domain with high homology to those implicated in phorbol ester and diacylglycerol binding in protein kinase C (PKC) isozymes. We have expressed β2-chimaerin in Sf9 inse...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 272; no. 42; pp. 26488 - 26496
Main Authors Caloca, Maria J., Fernandez, Nieves, Lewin, Nancy E., Ching, Dixie, Modali, Rama, Blumberg, Peter M., Kazanietz, Marcelo G.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 17.10.1997
Online AccessGet full text

Cover

Loading…
More Information
Summary:β2-chimaerin, a member of the GTPase-activating proteins for the small GTP-binding protein p21Rac, possesses a single cysteine-rich domain with high homology to those implicated in phorbol ester and diacylglycerol binding in protein kinase C (PKC) isozymes. We have expressed β2-chimaerin in Sf9 insect cells using the baculovirus expression system and determined that, like PKCs, β2-chimaerin binds phorbol esters with high affinity in the presence of phosphatidylserine as a cofactor. Scatchard plot analysis using the radioligand [3H]phorbol 12,13-dibutyrate revealed a dissociation constant of 1.9 ± 0.2 nm for β2-chimaerin. Likewise, β2-chimaerin is a high affinity receptor for the bryostatins, a class of atypical PKC activators. A detailed comparison of structure-activity relations using several phorbol ester analogs revealed striking differences in binding recognition between β2-chimaerin and PKCα. Although the diacylglycerol 1-oleoyl-2-acetylglycerol binds with similar potency to both β2-chimaerin and PKCα, the mezerein analog thymeleatoxin has 56-fold less affinity for binding to β2-chimaerin. To establish whether β2-chimaerin responds to phorbol esters in cellular systems, we overexpressed β2-chimaerin in COS-7 cells and monitored its subcellular distribution after phorbol ester treatment. Interestingly, as described previously for PKC isozymes, β2-chimaerin translocates from cytosolic to particulate fractions as a consequence of phorbol ester treatment. Our results demonstrate that β2-chimaerin is a novel target for the phorbol ester tumor promoters. The expansion of the family of phorbol ester receptors strongly suggests a potential for the “non-kinase” receptors as cellular mediators of the phorbol ester responses.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.272.42.26488